19 June 2013
Keywords: coley, cpg, boosts, hep, vaccine, physician-sponsored, study
Article | 24 February 2003
A physician-sponsored study of Coley Pharmaceuticals' ProMune (CpG 7909)has revealed that the drug can hasten and improve the protective
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 February 2003
© 2013 thepharmaletter.com